Bio-Techne operates in a highly competitive life sciences tools and clinical diagnostics market, facing rivalry from other global giants that also manufacture research reagents, proteins, and analytical instrumentation. Its primary competitors include Thermo Fisher Scientific, which offers a massive, vertically integrated portfolio of life science solutions; Danaher Corporation (through its Life Sciences segment); Merck KGaA (Sigma-Aldrich); and Promega. These companies also provide essential laboratory tools, antibodies, and high-quality reagents required by academic and commercial researchers. Additionally, Bio-Techne competes with smaller, niche firms that specialize in specific areas like monoclonal antibody development, flow cytometry, or automated protein analysis. The competitive landscape is defined by constant innovation, where companies must consistently release higher-precision, more reliable, and more automated products to maintain their market share and solidify their role as the preferred "supplier of choice" for modern pharmaceutical and diagnostic R&D.